Swedish Orphan Biovit Ord (BIOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,499 | 22,024 | 87,231 | 77,975 | 112,439 |
| Receivables | 310,877 | 283,626 | 505,672 | 451,343 | 288,770 |
| Inventories | 286,738 | 221,896 | 181,818 | 187,478 | 169,441 |
| Other current assets | 0 | 0 | 104 | 0 | 0 |
| TOTAL | $616,114 | $527,547 | $774,824 | $774,773 | $570,650 |
| Non-Current Assets | |||||
| PPE Net | 63,619 | 61,420 | 53,250 | 54,804 | 53,035 |
| Investments And Advances | 19,176 | 60,386 | 43,408 | 5,290 | 46,354 |
| Intangibles | 4,200,672 | 3,759,727 | 3,938,665 | 3,958,190 | 2,753,759 |
| Other Non-Current Assets | 78,735 | 0 | -1 | 37,453 | -1 |
| TOTAL | $4,362,202 | $3,881,532 | $4,035,323 | $4,055,737 | $2,853,147 |
| Total Assets | $4,978,315 | $4,409,183 | $4,810,148 | $4,830,616 | $3,423,694 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 237,782 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 46,699 | 47,150 | 50,453 | 72,050 | 36,227 |
| Accrued Expenses | N/A | N/A | N/A | 321,526 | N/A |
| Other current liabilities | 492,936 | 487,531 | 536,130 | 173,618 | 388,786 |
| TOTAL | $790,051 | $546,262 | $597,150 | $607,398 | $434,408 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,213,615 | 1,242,351 | 1,558,144 | 1,707,718 | 906,505 |
| Other Non-Current Liabilities | 463,721 | 695,055 | 722,299 | 329,990 | 445,057 |
| TOTAL | $2,069,429 | $1,937,406 | $2,280,443 | $2,431,919 | $1,351,562 |
| Total Liabilities | $2,859,480 | $2,483,668 | $2,877,594 | $3,039,422 | $1,786,075 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | N/A | 17,457 | N/A |
| Retained earnings | N/A | N/A | N/A | 769,060 | N/A |
| Other shareholders' equity | 2,118,835 | 1,925,515 | 1,932,554 | -21,266 | 1,637,618 |
| TOTAL | $2,118,835 | $1,925,515 | $1,932,554 | $1,791,194 | $1,637,618 |
| Total Liabilities And Equity | $4,978,315 | $4,409,183 | $4,810,148 | $4,830,616 | $3,423,693 |